Welcome to
Noden Pharma

PRINCIPLED, DEDICATED, UNIQUE

Noden Pharma DAC

Noden Pharma DAC is a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a broad range of therapeutic areas in international markets. The company focuses its resources on acquiring and optimizing established medicines. Corporate headquarters are located in Dublin, Ireland.

Principled

In today’s environment, behaving with integrity and honesty is essential to creating a culture which promotes high ethical standards. At Noden, we strive to be a responsible corporate citizen employing a principled approach which is prevalent throughout all interactions.

Dedicated

Noden is committed to providing medicines, in a responsible manner, which enhance the lives of people around the world. Advancing positive health outcomes is the goal for Noden and the shared focus for all employees.

Unique

Noden offers a unique proposition as a small company with a global platform. We are also differentiated based on our view of specialty pharma. At Noden we take a discerning view on product selection and asset optimization.

Origin of Noden

Noden is derived from "Nodens" a Celtic deity associated with healing and hunting. The name Nodens is cognate with Nuada, an important figure from Irish mythology. Nuada was a great hunter and the first king of the Tuatha Dé Danann, who was disqualified from kingship after losing his hand in battle. However, his hand was restored after he was given a working silver one by the divine-smith.

He was also worshipped in ancient Britain, most notably in a temple complex at Lydney Park in Gloucestershire between 300 to 500 AD. The devoted made offerings of small bronze representations of their diseased limbs. He was sometimes identified with the protective Mars or the regenerative Silvanus and his companion and symbol was a deerhound whose lick could cure the afflicted.

Noden Pharma DAC connects with Nodens as it is a company that values highly the core principles behind the Nodens legacy; Healing: Improving health outcomes and quality of life. Hunt: Product search and acquisition is an integral part of our strategy. In fact, the Noden Pharma emblem depicts a bird in full flight and each of its multi-coloured wings are formed in the shape of the healing hands of Nodens.

Management Team

Alan MARKEY, CEO
Noden Pharma DAC

Mr Markey has over 25 years’ executive experience in the International Pharmaceutical and Medical Device Sectors. He began his career in healthcare with Johnson and Johnson as a Marketing Manager. In 1997 he joined Wyeth Pharmaceuticals (acquired by Pfizer Inc) where he held a variety of commercial roles of increasing responsibility, including Sales and Marketing Director Ireland. In 2007 he was appointed Vice President EMEA for Pfizer’s Inflammation Division and was a key member of the company’s European Operating Committee. Before joining Noden, he was Managing Director of Baxter Healthcare Ireland, where he led several large transformation initiatives. As a Chartered Director, he has broad experience in both Executive and Non-Executive Director Roles. He is also a past Chairman of the Irish Surgical and Medical Trade Association. Mr Markey is a member of the Chartered Institute of Marketing, is a registered Chartered Director and holds an MBA (Finance) from Middlesex University.

Ciara WALSH, Head of Regulatory Affairs and Pharmacovigilance

Ciara is a senior pharmaceutical regulatory professional with over 18 years of collaborative experience working on projects with varied pharmaceutical assets, geographic regions, therapeutic areas, in small to medium sized pharmaceutical companies. She started her career in Quality and Regulatory Compliance at Gerard Laboratories, now part of the Mylan group, from 2000 to 2008. She moved into Regulatory Affairs in 2008 at Labopharm Europe Ltd managing the portfolio through two company acquisitions at Paladin Labs Europe and cumulating in the appointment as Director, Regulatory Affairs at Endo Ventures Ltd. In this role she was responsible for the global product registrations, agency interactions, and cross-functional liaison for product maintenance. Ciara holds a BSc from University College Dublin, Ireland.

Michael CONLAN, Group Financial Controller
Noden Pharma DAC

Michael brings 10 years of accounting and financial reporting experience to the role. Before joining Noden in December 2016, Michael worked with KPMG for 7 years in both the Audit and Advisory departments. At the time of his departure, he was an Audit Manager handling a number of engagements including high profile public interest entities and companies in the life sciences sector. Michael joined Noden in December 2016 as Finance Manager and was promoted to Associate Financial Controller in August 2017 before becoming Group Financial Controller in May 2019. He is a Chartered Accountant and holds a Bachelor of Commerce International degree from University College Dublin.

Loretta CUNNINGHAM, Head of Quality
Noden Pharma DAC

Ms Cunningham is a senior pharmaceutical quality professional with 13 years of collaborative experience working within the Pharmaceutical and Biopharmaceuitcal companies including Chanelle Pharmaceuticals Manufacturing Ltd, PPD, Pfizer and Alexion. Prior to joining Noden Pharma DAC Ms Cunningham held a number of roles with increasing responsibilities throughout her career to date. Following 9 years experience in a Senior QA function at the leading generic pharmaceutical company Ms Cunningham joined PPD where she was responsible the QA oversight of Phase I, II and III Clinical Trials. Ms Cunningham joined Pfizer in 2015 as Contract Operations Quality Manager responsible for CMO management of Pfizer products within the European, US and ROW markets managing ongoing metrics, regulatory variations, change control management and oversight of the quality deviations and complaints process. Most recently Ms Cunningham was QA Manager, Finished Product for Multinational Biopharmaceutical manufacturer Alexion where she managed a Quality Team responsible for the Global complaints process, contract packaging and release sites based in UK, US and Japan, internal packaging and QA disposition in the Ireland division and QA oversight of validation activities. Ms. Cunningham holds a Bachelor of Science in Quality Management from the Institute of Technology Sligo, Ireland, as well as Diploma in Quality Management from Institute of Technology Galway, Ireland. Ms. Cunningham is also a certified IRCA Lead Auditor.

Aliskiren (Tekturna®)

Tekturna® is available in 150mg and 300mg tablets as well as in combination with hydrochlorothiazide (HCT) (150mg/12.5mg, 150mg/25mg, 300mg/12.5mg, 300mg/25mg)
tekturna
For more information, please visit www.tekturna.com
Please see full prescribing information, including Boxed Warning, for Tekturna
Please see full prescribing information, including Boxed Warning, for Tekturna HCT